What is the EBMT
What is the EBMT?Related Meetings
MembershipRegistryWorking PartiesNurses GroupDirectoryTransplant GuidelinesCorporate Sponsorship

Lymphoma

Last updated: 07.04.2006

Introduction
Meetings

Courses & Training
Training
Sub-Committees
Ongoing Studies
Publications
Members

LWP Annual Educational Course Presentations

Session 1: Hematopoietic Stem Cell Transplantation Lymphoproliferative Disorders

EBMT Survey for Hematopoietic Stem Cell Transplantation for Lymphomas
Anna Sureda
Hospital de la Santa Creu i Sant Pau

The Role of Hematopoietic Growth Factors in Hematopoietic Stem Cell Transplantation
Marek Trnený
Charles University Hospital

Session 2: Hematopoietic Stem Cell Transplantation in Hodgkin´s Lymphoma

The Role of Salvage Therapy Before the Autologous Procedure in Hodgkin’s Lymphoma
Andreas Josting
University Hospital Cologne

Autologous Stem Cell Transplantation for Refractory / Relapsed Hodgkin’s Lymphoma
Andreas Josting
University Hospital Cologne

Is There Any Evidence of a Graft Versus Lymphoma Effect in the Setting of Hodgkin’s Lymphoma?
Anna Sureda
Hospital de la Santa Creu i Sant Pau

The Use of Monaclonal Antibodies in Hodgkin’s Lymphoma
Peter Borchmann
University Hospital Cologne

Case Studies session 2:

Management Dilemmas of a Young Patient with Multireplapsed Hodgkin's Lymphoma
Mathew Winter
Weston Park Hospital Sheffield

Refractory Hodgkin’s Lymphoma Treated with Reduced-Intensity HLA-Identical Unrelated-Donor Stem Cell Transplantation After High-Dose Treatment with Autologous Rescue, and Modified Salvage Therapy Including Rituximab
Markus Seidel
St. Anna Kinderspital and Children's Cancer Research Institute

Session 3: Hematopoietic Stem Cell Transplantation for High-Grade Lymphoproliferative Disorders

Autologous Stem Cell Transplantation for Non-Hodgkin’s Lymphoma
Dolores Caballero
Hospital Clínico

The Role of Intensive Therapy in T-Cell Lymphoproliferative Disorders
Norbert Schmitz
AK St. Georg

Monoclonal Antibodies in the Setting of Autologous Stem Cell Transplantation
Christian Gisselbrecht
Hôpital St. Louis

The Role of Allogeneic Stem Cell Transplantation in Non-Hodgkin’s Lymphoma
Rodrigo Martino
Hospital de la Santa Creu i Sant Pau

Case Studies session 3:

Autologous Peripheral Blood Stem Cell Transplantation in 31-Year Old Man with High Intermediate Risk, Replased Diffuse Large B/Cell Lymphoma
Anna Dabrowska-Iwanicka
The Maria Sklodowska-Curie Memorial Cancer Centre, Warsaw

Allergenic Peripheral Blood Stem Cell Transplantation for Refractory Cutaneous T-Cell Lymphoma Birte Friedrichs
AK St. Georg, Hamburg

Session 4: Hematopoietic Stem Cell Transplantation for Low-Grade Lymphoproliferative Disorders

Present Role of Autologous Hematopoietic Stem Cell Transplantation in Low-Grade Lymphoproliferative Disorders
Harry Schouten
University Hospital Maastricht

In Vitro/Vivo Purging in Autologous Stem Cell Transplantation
Harry Schouten
University Hospital Maastricht

Radioimmunotherapy For Low-Grade Lymphoproliferative Disorders
Marinus H.J. van Oers
Academic Medical Center

Allogeneic Stem Cell Transplantation in Low-Grade Lymphoproliferative Disorders
Steve Mackinnon
Royal Free Hospital and School of Medicine

Case Study session 4:

Allogeneic Transplantation for Refractory Follicular Non Hodgkin Lymphoma in a 54 Year Old Male
Tessa Kerre
University Hospital Ghent

 

 

     


What is the EBMT? | Related Meetings | Membership | Registry | Working Parties
Nurses Group | Directory | Transplant Guidelines | Corporate Sponsorship

HOME | SITE MAP | RELATED LINKS | CONTACT US